SIGA Technologies, Inc. (SIGA)
- Previous Close
5.93 - Open
5.92 - Bid 5.88 x 100
- Ask 5.96 x 100
- Day's Range
5.88 - 6.03 - 52 Week Range
4.95 - 12.83 - Volume
401,746 - Avg. Volume
542,641 - Market Cap (intraday)
422.931M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
8.84 - EPS (TTM)
0.67 - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 29, 2025
- 1y Target Est
--
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
www.siga.com46
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: SIGA
View More
Performance Overview: SIGA
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SIGA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SIGA
View MoreValuation Measures
Market Cap
422.93M
Enterprise Value
261.22M
Trailing P/E
8.84
Forward P/E
8.97
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.54
Price/Book (mrq)
1.96
Enterprise Value/Revenue
2.17
Enterprise Value/EBITDA
4.58
Financial Highlights
Profitability and Income Statement
Profit Margin
40.33%
Return on Assets (ttm)
14.40%
Return on Equity (ttm)
25.47%
Revenue (ttm)
120.33M
Net Income Avi to Common (ttm)
48.53M
Diluted EPS (ttm)
0.67
Balance Sheet and Cash Flow
Total Cash (mrq)
162.27M
Total Debt/Equity (mrq)
0.56%
Levered Free Cash Flow (ttm)
4.77M